SKI Market

A+| A| A-|

Indian Indices

Sensex

76,034.42 -829.29
( -1.08%)

Global Indices

Nasdaq

47,431.94 -295.58
(-0.62%)

Dow Jones

6,795.43 -7.05
(-0.10%)

Hang Seng

54,230.47 -794.90
(-1.44%)

Nikkei 225

10,300.41 -53.36
(-0.52%)

Forex

USD-INR

91.90 -0.24
(-0.26%)

EUR-INR

106.87 0.29
(0.27%)

GBP-INR

123.51 0.42
(0.34%)

JPY-INR

0.58 0.00
(0.09%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Citurgia Biochemicals Ltd

Industry : Chemicals

BSE Code

ISIN Demat

Book Value()

506373

INE795B01031

-0.7445334

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CITURGIBIO

1734.41

EPS(TTM)

Face Value()

Div & Yield %

Back

maha rashtra apex corporation ltd

Glenmark Pharmaceuticals consolidated net profit rises 15.88% in the December 2025 quarter

Jan 31,2026

Net profit of Glenmark Pharmaceuticals rose 15.88% to Rs 403.21 crore in the quarter ended December 2025 as against Rs 347.96 crore during the previous quarter ended December 2024. Sales rose 17.75% to Rs 3888.00 crore in the quarter ended December 2025 as against Rs 3301.90 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	3888.00	3301.90	18
OPM %	22.37	18.18	-
PBDT	872.79	579.06	51
PBT	718.34	456.33	57
NP	403.21	347.96	16

76,034.42 -829.29 ( -1.08%)

47,431.94 -295.58 (-0.62%)

6,795.43 -7.05 (-0.10%)

54,230.47 -794.90 (-1.44%)

10,300.41 -53.36 (-0.52%)

91.90 -0.24 (-0.26%)

106.87 0.29 (0.27%)

123.51 0.42 (0.34%)

0.58 0.00 (0.09%)